| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| R&D Expense | $86.2M | +7.3% |
| SG&A Expense | $54.3M | +77.4% |
| Operating Income | -$140.4M | -26.7% |
| Pre-tax Income | -$126.6M | -36.3% |
| Income Tax | $0 | — |
| Net Income | -$126.6M | -36.3% |
| EPS (Basic) | -$3.44 | -3.3% |
| EPS (Diluted) | -$3.44 | -3.3% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.8M | -43.5% |
| Current Assets | $225.7M | +31.0% |
| Total Assets | $235.4M | +28.5% |
| Current Liabilities | $22.8M | +51.7% |
| Stockholders' Equity | $206.6M | +28.3% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.2M | -18.6% |
| Capital Expenditures | $42K | -96.5% |
| Investing Cash Flow | -$84.7M | -304.6% |
| Financing Cash Flow | $150.7M | +159.3% |
| Free Cash Flow | -$89.3M | -16.8% |